185 related articles for article (PubMed ID: 25557765)
21. Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells.
Díaz-Lezama N; Hernández-Elvira M; Sandoval A; Monroy A; Felix R; Monjaraz E
Biochem Biophys Res Commun; 2010 Dec; 403(1):24-9. PubMed ID: 21040709
[TBL] [Abstract][Full Text] [Related]
22. Melatonin affects voltage-dependent calcium and potassium currents in MCF-7 cell line cultured either in growth or differentiation medium.
Squecco R; Tani A; Zecchi-Orlandini S; Formigli L; Francini F
Eur J Pharmacol; 2015 Jul; 758():40-52. PubMed ID: 25843408
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells.
Mariot P; Vanoverberghe K; Lalevee N; Rossier MF; Prevarskaya N
J Biol Chem; 2002 Mar; 277(13):10824-33. PubMed ID: 11799114
[TBL] [Abstract][Full Text] [Related]
24. CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells.
Gackière F; Bidaux G; Delcourt P; Van Coppenolle F; Katsogiannou M; Dewailly E; Bavencoffe A; Van Chuoï-Mariot MT; Mauroy B; Prevarskaya N; Mariot P
J Biol Chem; 2008 Apr; 283(15):10162-73. PubMed ID: 18230611
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol induces intracellular Ca(2+) rise via T-type Ca(2+) channels in a mesothelioma cell line.
Marchetti C; Ribulla S; Magnelli V; Patrone M; Burlando B
Life Sci; 2016 Mar; 148():125-31. PubMed ID: 26845536
[TBL] [Abstract][Full Text] [Related]
26. T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells.
Ohkubo T; Yamazaki J
Int J Oncol; 2012 Jul; 41(1):267-75. PubMed ID: 22469755
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory gene expression of the Cav3.1 T-type calcium channel to improve neuronal injury induced by lidocaine hydrochloride.
Wen X; Xu S; Zhang Q; Li X; Liang H; Yang C; Wang H; Liu H
Eur J Pharmacol; 2016 Mar; 775():43-9. PubMed ID: 26852957
[TBL] [Abstract][Full Text] [Related]
28. The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stress.
Louis M; Rosato RR; Brault L; Osbild S; Battaglia E; Yang XH; Grant S; Bagrel D
Int J Oncol; 2004 Dec; 25(6):1701-11. PubMed ID: 15547708
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitor sodium butyrate promotes the osteogenic differentiation of rat adipose-derived stem cells.
Hu X; Fu Y; Zhang X; Dai L; Zhu J; Bi Z; Ao Y; Zhou C
Dev Growth Differ; 2014 Apr; 56(3):206-13. PubMed ID: 24494796
[TBL] [Abstract][Full Text] [Related]
30. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
31. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
[TBL] [Abstract][Full Text] [Related]
32. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
[TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin-3-gallate elicits Ca2+ spike in MCF-7 breast cancer cells: essential role of Cav3.2 channels.
Ranzato E; Magnelli V; Martinotti S; Waheed Z; Cain SM; Snutch TP; Marchetti C; Burlando B
Cell Calcium; 2014 Oct; 56(4):285-95. PubMed ID: 25260713
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor signaling regulates T-type Ca
Hall M; Todd B; Allen ED; Nguyen N; Kwon YJ; Nguyen V; Hearne JL; Martin-Caraballo M
Am J Cancer Res; 2018; 8(4):732-747. PubMed ID: 29736318
[TBL] [Abstract][Full Text] [Related]
35. High doses of the histone deacetylase inhibitor sodium butyrate trigger a stress-like response.
Gagliano H; Delgado-Morales R; Sanz-Garcia A; Armario A
Neuropharmacology; 2014 Apr; 79():75-82. PubMed ID: 24212060
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation and nuclear localization of survivin by sodium butyrate induces caspase-dependent apoptosis in human oral mucoepidermoid carcinoma.
Jang B; Yang IH; Cho NP; Jin B; Lee W; Jung YC; Hong SD; Shin JA; Cho SD
Oral Oncol; 2019 Jan; 88():160-167. PubMed ID: 30616788
[TBL] [Abstract][Full Text] [Related]
37. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
Rocchi P; Tonelli R; Camerin C; Purgato S; Fronza R; Bianucci F; Guerra F; Pession A; Ferreri AM
Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor-induced neuroendocrine differentiation and apoptotic resistance of androgen-independent human prostate cancer cells.
Humez S; Monet M; Legrand G; Lepage G; Delcourt P; Prevarskaya N
Endocr Relat Cancer; 2006 Mar; 13(1):181-95. PubMed ID: 16601287
[TBL] [Abstract][Full Text] [Related]
39. Keratin 23 (K23), a novel acidic keratin, is highly induced by histone deacetylase inhibitors during differentiation of pancreatic cancer cells.
Zhang JS; Wang L; Huang H; Nelson M; Smith DI
Genes Chromosomes Cancer; 2001 Feb; 30(2):123-35. PubMed ID: 11135429
[TBL] [Abstract][Full Text] [Related]
40. The effects of calcium channel blockade on proliferation and differentiation of cardiac progenitor cells.
Hotchkiss A; Feridooni T; Zhang F; Pasumarthi KB
Cell Calcium; 2014 May; 55(5):238-51. PubMed ID: 24680380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
